chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Evening after shot, I started feeling ill, running low grade temp, arm sore and swollen. Next evening I went back to the pharmacist, who involved the Clinic Nurse who suggested I go to the emergency room at Hospital. I was seen in the emergency room by doctor who diagnosed Cellulitis, and I was given 7 days of KEFLEX 500 mg. I also have photos of condition of left arm.
I had swelling on my forehead, between my eyebrows, down the bridge of my nose, and,  both sides of the bridge of my nose.; This is a spontaneous report from a contactable nurse (patient). A 49-year-old female patient received bnt162b2 (BNT162B2), via an unspecified route of administration, administered in left arm on 12Jan2021 09:30 (Batch/Lot Number: EJ1686) (at the age of 49 years old) as 1st dose, single for COVID-19 immunisation. The patient was not pregnant at the time of vaccination. Medical history included penicillin allergy. No other vaccine in four weeks and no other medications in two weeks. The patient experienced swelling on forehead between eyebrows, down the bridge of my nose, and both sides of the bridge of my nose on 13Jan2021 06:30. No treatment for the event. No COVID prior vaccination. The patient underwent lab tests and procedures which included Nasal Swab: negative on 12Feb2021. The outcome of the event was recovered on unspecified date.  Follow-up attempts are completed. No further information is expected.
Miscarriage. 12/04/09 Antenatal record received for DOS 10/27/09. IUP: 6 weeks. EDD: 06/18/10; Additional record for DOS  11/23/09:  Diagnosis: missed SAB.
pt recvd vax spiked fever of 104.4 R that evening; tx'd w/APAP fever up & down throughtout the next day; pt seen by pvt MD thought to have a summer virus; no ther sx; pt active & eating well;
I had the second vaccine in April and still have a bump on my arm and so hard to move it, very painful.; I had the second vaccine in April and still have a bump on my arm and so hard to move it, very painful.; I had the second vaccine in April and still have a bump on my arm and so hard to move it, very painful.; swollen for 3 weeks after second; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A 59 year-old patient received bnt162b2 (BNT162B2), administered in arm left, administration date 04Apr2021 (Lot number: ER18735) as dose 2, single and administration date 04Nov2021 (Lot number: FH8030) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose 1, Manufacturer unknown, Lot number: EN6204, Anatomical site : Intramuscular, Route of administration: Left arm), administration date: 14Mar2021, for COVID-19 Immunization. The following information was reported: LIMB DISCOMFORT (non-serious), MOVEMENT DISORDER (non-serious), PAIN IN EXTREMITY (non-serious) all with onset 2021, outcome "not recovered" and all described as "I had the second vaccine in April and still have a bump on my arm and so hard to move it, very painful."; PERIPHERAL SWELLING (non-serious) with onset 2021, outcome "not recovered", described as "swollen for 3 weeks after second".  Additional information: Very healthy women 59 years at time of vaccine. It was so swollen for 3 weeks after second. Then she hasn't had full mobility in left arm since. When she has check-up in July her doctor said people get covid arm, but this was ridiculously painful. Can't hook her bra or so certain stretches/ exercises. She was on zero medications.  No follow-up attempts are possible. No further information is expected.
Copper taste in mouth, increased mucus making it difficult to swallow, neck/back/shoulder stiffness, fuzzy vision, dull headache, left-sided chest ache.
that evening itched all over next noc itchy-following morning hives all over body, trunk, arms, legs, ears, face, feet;called MD told to give DPH-baking soda baths-DPH for wk & hives better;
Beginning January 15, 2021, I began experiencing symptoms of transverse myelitis: Pain in the lower back, sharp shooting pain down the legs, numbness, tingling, burning sensation  in legs and feet, increased sensitivity to touch, cold and heat; weakness in the lower limbs, bladder and bowel problems. The symptoms were crippling and nothing helped control them.  Finally on March 23, 2021, the symptoms began to subside.
Weight loss; Has been in bed since getting the vaccine; Hasn't been able to eat; Feeling woozy; Unable to go to work; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 64 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 2021 (Lot number: EW0186) at the age of 64 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Losing her taste and smell" (unspecified if ongoing), notes: Prior to getting the vaccine she was losing her taste and smell; "Losing her taste and smell" (unspecified if ongoing), notes: Prior to getting the vaccine she was losing her taste and smell. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose: 1, Lot: EW0185, Route, Anatomical Location: Right arm), administration date: 16Jul2021, when the patient was 64 years old, for COVID-19 Immunization, reaction(s): "Her arm hurt". The following information was reported: BEDRIDDEN (non-serious) with onset 07Aug2021, outcome "not recovered", described as "Has been in bed since getting the vaccine"; WEIGHT DECREASED (non-serious) with onset 09Aug2021, outcome "unknown", described as "Weight loss"; DIZZINESS (non-serious) with onset 01Aug2021, outcome "not recovered", described as "Feeling woozy"; EATING DISORDER (non-serious) with onset 06Aug2021, outcome "not recovered", described as "Hasn't been able to eat"; LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (non-serious) with onset 2021, outcome "unknown", described as "Unable to go to work".  Additional information: No Investigation Assessment was done. Patient took the Pfizer Covid shot on Friday after work. She has been in bed since then. Her weight was 106lbs. She is down to 104lbs. She hasn't been eating anything. Patient weighs daily. On Friday she was 106lbs. She got the shot after work and started feeling woozy. Prior to getting the vaccine she was losing her taste and smell. She missed a lot of work because of that and she was in pain. She went and was tested. The result was negative. She takes medication for low potassium. She also takes a water pill. She does not know the names. No history of all previous immunization with the Pfizer vaccine considered as suspect. No Additional Vaccines administered on same date of the Pfizer Suspect. AE did not required Emergency Room and Physician Office visit. No Relevant Tests were done. Patient can't go to work. She feels like crap. This did something to her.  No follow-up attempts are possible. No further information is expected.
On 4/16/2021 I received a phone call from public health informing us that the patient died on 3/31/2021.
Breakthrough case admission after 3 vaccines Moderna 3/18/21 Lot# 002B21A;  Moderna 4/15/21 Lot# 025B21A;  Moderna 2/17/22 Lot# 042J21A
Covid-19; Covid-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient. A 42-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 02Nov2021 as dose 3 (booster), single (Lot number: Ff2593) at the age of 42 years, in left arm for covid-19 immunisation; COVID-19 Vaccine - Manufacturer Unknown, as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant) with onset 24Apr2022, outcome "unknown", COVID-19 (medically significant) with onset 24Apr2022, outcome "not recovered" and all described as "Covid-19". Adverse event: I started taking Paxlovid on day 0 of my infection and had no symptoms by Day 2. I started testing negative for Covid on days 6 and 8 of my infection. I stopped taking Paxlovid on day 5. On the evening of day 8, I had a sore throat and on day 9 worsening cold symptoms and a positive at-home Covid test. My family stopped masking and isolating due to the negative test on day 6 but 2 members of my family tested positive on my day 11 and I can only assume it was because I was contagious on days 8-11. Ae resulted in: [None of the above]. Anti-viral details: Product: COVID 19 Treatment, Brand: Paxlovid, Treatment start date: 16Apr2022, Treatment stop date: 21Apr2022, Indication: Treatment of COVID-19. Other medication in 2weeks: No. The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (16Apr2022) Positive, notes: I started taking Paxlovid on day 0 of my infection; (22Apr2022) Negative, notes: I started testing negative for Covid on days 6 and 8 of my infection; (24Apr2022) Positive, notes: positive at-home Covid test; (24Apr2022) Negative, notes: I started testing negative for Covid on days 6 and 8 of my infection. Therapeutic measures were not taken as a result of covid-19. Covid vaccine details: vaccine brand: Pfizer / BioNTech, Vaccine brand unknown: False.   No follow-up attempts are possible. No further information is expected
Sore muscles around rib cage.  Sore ankles. Headache. Fatigue.  Lasted about 48 hours.
Next day left arm soreness lasted 2 days. Also 2nd day started feeling tired, exhausted for 1 week and nauseous for about 4-5 days. I fely hung over, achey, had slight fever and chills for 5 days. I am feeling 95% better now going on 9 days. I'm scared 2nd shot will be worse?
Warm and tickling in throat.  No signs or symptoms of distress.  PS02 100%  pulse 99  Respirations even and unlabored. Skin pink warm and dry.
painful shingles; This is a spontaneous report based on the information received by Pfizer. A contactable consumer reported for a patient (family member) of unspecified age and gender received bnt162b2 (PFIZER BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: Not reported) via an unspecified route of administration on an unspecified date as dose number unknown, single for COVID-19 immunization. Product was reported as Shingles vaccine. The patient's medical history and concomitant medications were not reported. It was reported that family member struggling for over two months now with painful shingles. Which occurred a week after Pfizer/BioNTech mRNA vaccine was administered. Doctors then told them, it was a possible side effect and hes looking at least year before it will clear up. Social media team became aware of potential AE was reported as 18Aug2021. Date the Author published the social media post was reported as 18Aug2021 6:35:58 PM. The outcome of the event was not recovered.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Lump at point of injection. Pain. ER Assessment: local nodule with redness at injection site. Supportive Care
Felt dizzy; Not been drinking enough water recently; Might be dehydrated; Stated she has been drinking water and her urine went to clear from yellow; Severely obese; This is a spontaneous report from a contactable consumer (patient herself) via a medical information team. A 68-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EN5318), via an unspecified route of administration in left arm on 05Feb2021 (Friday) at 09:48 (at the age of 68-year-old) as a single dose for COVID-19 immunisation. The patient's medical history included ongoing blood pressure, dehydration, hospitalization. Mentioned in the past she had a hospitalization for dehydration. Concomitant medication included felodipine, orally from an unspecified date (taking for years) and ongoing at 5 mg once a day (5 mg take once daily by mouth) for blood pressure. No history of all previous immunization with the Pfizer vaccine considered as suspect. No additional vaccines administered on same date of the Pfizer suspect. No prior vaccinations (within 4 weeks). Patient's medical history (including any illness at time of vaccination) was none. Family medical history was none. It was reported that, patient did not experience any immediate adverse event, however, today (08Feb2021) she felt dizzy, asked if: There are reports of other patients feeling dizzy days after vaccination, dizziness was usually followed by other side effects. Patient acknowledged she has not been drinking enough water recently (08Feb2021), considered the dizziness experienced may be a result of that and probably not an adverse event associated to the COVID-19 vaccine. She didn't have any side effects for three days and then she began to feel dizzy. Adds that it was not too bad as she was able to work but it was persisting. Mentioned she read that dizziness could be a severe side effect and she was asking could it come on three days later. Adds that she might be dehydrated on 08Feb2021 and stated she has been drinking water and her urine went to clear from yellow on 08Feb2021. Mentioned she didn't drink enough water on Saturday or Sunday, so she was trying to make that up today. Also asking would she have other side effects along with the dizziness if this was a side effect. Mentioned in the past she had a hospitalization for dehydration. Asking to have any of you girls heard anything about this. Mentioned that she was severely obese on an unspecified date in 2021. Adds she was scheduled to receive the second dose of the vaccine on 26Feb2021. The adverse events did not require a visit to physician or emergency room. No relevant test. No investigation assessment. The events were considered as non-serious by the consumer. The outcome of the event felt dizzy was not resolved and unknown for the other events.  Follow-up attempts completed. No further information expected.
Got injection on Tuesday June 2. On June 6 in the evening I started to feel dizzy, faint, foggy feeling in my head. Almost like a stroke type symptoms. I was unable to ambulate. I got real tired and just felt like going to sleep. I laid down around 5 pm and got up at 5 am. I do not sleep more than 4 or 5 hours nightly. I went to ER due to not feeling any better. I was admitted to the hospital immediately.
Extreme injection site pain lasting for 48 hours+, low grade fever, maculopapular rash on torso, arthralgia.
Swelling, pain, bleeding, Hives on neck Left arm chest at 3:00PM.  Difficulty swallowing and hard to catch breath by 5:00 PM. Took Benadryl and Tylenol went to bed at 5:10 PM. Woke up 9 PM crying in pain. Took Advil and more Benadryl, laid in bed in pain. 12 AM took Tylenol and more Benadryl for pain and swelling in my arm and armpit and lymph nodes in neck, left cheek and armpit  hot to the touch and very painful. 01/14/2017 returned to Clinic and showed the nurse who said she would report it and wrote a note saying to never receive the FLUZONE flu shot again.
bell's palsy; A spontaneous report was received from a healthcare professional (HCP) concerning a 56-year-old, male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced Bell's Palsy/facial paralysis.  The patient's medical history was not provided.  Concomitant products known to have been used by the patient, within two weeks prior to the event, included valsartan, insulin, insulin degludec, rosuvastatin, and acetylsalicylic acid.  On 12 Jan 2021, prior to the onset of the events, the patient received their dose of mRNA-1273 (lot number: 06L20A) intramuscularly in his left arm for prophylaxis of COVID-19 infection.  The patient experienced Bell's Palsy on 25 Jan 2021.    Treatments of these events were not provided.  Action taken with mRNA-1273 in response to the events was not reported.  The outcome of the event, Bell's Palsy/facial paralysis was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.    .
run down, brief dizziness, difficulty walking, and tried to throw up, slept 12 hours, much better the next day but slight swelling and itchiness in my hands,
A report was received from a health care professional on 12/3/03 concerning eight vaccinees of unspecified sex and under 4 years of age who inadvertently received Fluvirin on an unspecified date. On an  unspecified date, eight vaccinees under 4 years of age inadvertently received Fluvirin. At the time of the report no adverse events had been reported. There was insufficient information to determine the reporter's causality. Update 1/20/04: Follow up information received from a health care professional indicated that a 2 year old male vaccinee inadvertently received Fluvirin on 11/26/03. No follow up pending.
Pain in stomach. Excessive urination. Fever of 101 on 2nd day . Has had this stomach pain since 1st vaccine on 2/20/21 and 2nd vaccine was on 3/13/2021.
couldnt get out of bed, buldge in back, body wont straighten out, bad pain in back, muscles very weak, cant walk too far
This spontaneous report has been received from a medical assistant referring to a 16 years old patient of unknown gender. No information was provided regarding the patients' medical history, concurrent conditions, drug and allergy history. Concomitant therapies included sterile diluent (MRK). On 22-SEP-2017, the patient were vaccinated with improperly stored doses VARIVAX (lot # N017396, expiration date 07-JUN-2019, dose and route was not provided) for prophylaxis. The doses of VARIVAX were exposed to a temperature excursion of 15 Fahrenheit (F) to 46 F during a time frame of 1 hour and 23 minutes, which was detected by the data logger. There was a previous temperature excursion of 6 F to 14 F for 1 hour and 16 minutes. No adverse effects were reported. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1711USA003604: US-009507513-1711USA003605: US-009507513-1711USA003602: US-009507513-1709USA011228.
Ocular migraine. No history of migraines or ocular problems of any kind. Partial lose of vision.  After vision was restored pain around eyes.
The daughter of the patient called pharmacy late Monday (11/07/2016) after stating her mother had received vaccines from us on 11/02/2016. She stated the arm where PREVNAR-13 was administered was swollen the size of a baseball and the back side of the arm where ZOSTAVAX was administered was red and itching. Staff advised the daughter to contact the prescribing physician, due to the length of time of the swelling. The pharmacist administering the vaccines stated that the patient insisted on receiving both vaccines in the same arm.
Euphoria; This spontaneous case was reported by a consumer and describes the occurrence of EUPHORIC MOOD (Euphoria) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 28-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Apr-2021, the patient experienced EUPHORIC MOOD (Euphoria). On 25-Apr-2021, EUPHORIC MOOD (Euphoria) had resolved.            No concomitant medication was reported.  No treatment medication use was reported.   This case was linked to MOD-2021-356492, MOD-2021-356638 (Patient Link).
infection with SARS-CoV-2 Omicron BA.1; infection with SARS-CoV-2 Omicron BA.1; This is a literature report.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 3 (booster), single, (Batch/Lot number: unknown) as dose 2, single and (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "infection with SARS-CoV-2 Omicron BA.1".; Sender's Comments: A possible contributory role of the suspect products cannot be excluded for the reported event drug ineffective based on the known safety profile and temporal association ,Linked Report(s) : US-PFIZER INC-202200256250 Same article/drug/events and different patients
Extreme body chills and muscle cramping started 7 hours after injection and didn?t subside until next morning. Ran a low grade fever for the entire day after vaccination as well as developing a mild cough. All symptoms faded within two days except for stiffness in the neck.
Diffuse myalgias,fever, cough beginning 2 days after vaccine and worsening times 5 days.
This spontaneous report was received from a pharmacy technician concerning a patient of an unknown age and gender. The patient's concurrent conditions, medical history, historical drugs and concomitant therapies were not reported. On 20-APR-2017, the patient was administered an expired dose of ZOSTAVAX lot number L046900, expiration date 23-FEB-2017 (dose and route were not reported) for prophylaxis. No adverse effects were reported. Additional information has been requested.
booster; There is now a purple discoloration of the nail bed of the big toes, more on the left foot than the right; About one week after the most recent vaccination, my toenails were hurting at night when I was trying to sleep.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 61 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 26Nov2021 11:45 (Lot number: FJ1620) at the age of 61 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Osteoporosis" (unspecified if ongoing); "Known allergies: Sulfa" (unspecified if ongoing). Concomitant medication(s) included: VITAMIN D; RECLAST. Past drug history included: Ampicillin, reaction(s): "Known allergies: Ampicillin"; Erythromycin, reaction(s): "Known allergies: Erythromycin". Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: ER8727, Location of injection: Arm Left, Vaccine Administration Time: 12:15 PM), administration date: 22Mar2021, when the patient was 60 years old, for COVID-19 Immunization; Bnt162b2 (Dose Number: 2, Batch/Lot No: EW0151, Location of injection: Arm Left, Vaccine Administration Time: 12:15 PM), administration date: 12Apr2021, when the patient was 60 years old, for COVID-19 Immunization. The following information was reported: IMMUNISATION (non-serious) with onset 26Nov2021 11:45, outcome "unknown", described as "booster"; NAIL DISCOLOURATION (non-serious) with onset Nov2021, outcome "unknown", described as "There is now a purple discoloration of the nail bed of the big toes, more on the left foot than the right"; NAIL DISCOMFORT (non-serious) with onset Nov2021, outcome "unknown", described as "About one week after the most recent vaccination, my toenails were hurting at night when I was trying to sleep.". Therapeutic measures were not taken as a result of nail discolouration, nail discomfort.  Additional information: No, covid prior to vaccination, covid was not tested to post vaccination.  No follow-up attempts are possible. No further information is expected.
Vaccine was given at Hospital at bout 12:15 PM on 5/4.   Weakness of muscles and inability to walk; tired feelings began  at about  8:55 PM.   Got up to walk to bathroom and could not complete the walk; only walked about 20 feet then need to be supported by husband and eventually lowered to sit on the floor.   Fire department was called to help load the patient in to a car for transport to Emergency Room at 1:00 AM on 5/5/21; patient was admitted to this hospital at about 5:00 AM for further testing and observation.  Patient is currently still hospitalized at that location.